Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a structured course help people at suicide risk build a personal safety plan?

NCT ID NCT06466356

Prevention Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests a psychoeducational course for people who have recently experienced a suicide attempt or are at high risk. The course teaches participants and their family members to identify personal triggers and early warning signs, and to create an individual safety plan. The study compares this course to a single session focused on safety planning, with both groups also receiving standard care. The main goal is to see if the course improves participants' confidence in handling future suicidal crises.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a psychoeducational course covering suicide-related topics, trigger identification, early warning signs, and individual safety planning, delivered to patients and their next of kin
What this could lead to
If effective, this course could provide a structured, scalable way to help people at risk of suicide recognize warning signs and build a personalized safety plan, potentially reducing future suicide attempts.
What could go wrong
This is a small, early-stage trial with 80 participants, so results may not apply broadly. The intervention adds to standard care, and its benefit over a single safety-planning session alone is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a suicide attempt, suicidal behavior, or risk of suicidal behavior and a clinician evaluating that the patient has an intention to die * Patients with a suicide attempt or suicidal behavior defined as "a self-inflicted, potentially injurious behavior with a non-fatal outcome for which there is evidence of intention of death and/or considered to have had or been close to a suicidal crisis syndrome. Exclusion Criteria: * Not being sufficiently fluent in Norwegian to provide informed consent, valid responses on psychometric testing or to benefit from a psychoeducative course. * A known diagnosis of ICD-10 F 60.3 (borderline personality disorder) with similar symptoms at previous admittances. * Ongoing psychosis. * A substance abuse condition to such a degree that they are unable to comply with the protocol and are considered to be at risk when attending psychoeducational courses. * Organic brain disorders or mental disabilities in such a degree that they are unable to comply with the protocol. * Not being able to give an informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Psychiatric disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychiatric disorder Stress, Psychological Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psychiatric disorder Psychiatric emergency Self-efficacy Stress, psychological Suicide prevention Suicide threat

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Helse Nord-Trøndelag

    RECRUITING

    Levanger, Trøndelag, 7600, Norway

  • St. Olav Hospital

    RECRUITING

    Trondheim, Trøndelag, 7006, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.